Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06777901 · ClinicalTrials.gov registry record · Phase 4
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
A Phase 4 study of Peripheral Arterial Diseases, sponsored by Angiodynamics.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 224
- Enrollment target
- 9
- Study locations
NCT06777901: Recruiting Phase 4 study of Peripheral Arterial Diseases, sponsored by Angiodynamics.
NCT06777901 is a Phase 4 study of Peripheral Arterial Diseases that is actively recruiting participants, run by Angiodynamics. The registered enrollment target is 224 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (57% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06777901, a Phase 4 study of Peripheral Arterial Diseases, is actively recruiting participants, sponsored by Angiodynamics.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 224 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, amputation, revascularization and improving patency? Researchers will compare the Auryon Atherectomy System with balloon angioplasty to balloon angioplasty alone.
Primary Outcome
The primary endpoint will be analyzed based on a Finkelstein-Schoenfeld/win-ratio approach, comparing pairs of subjects on the components of the composite endpoint in a hierarchical fashion: 1. Freedom from amputation 2. Freedom from CD-TLR 3. Primary Patency
Conditions Studied
Interventions
- DEVICE Auryon Atherectomy System
- DEVICE Balloon Angioplasty
Study Locations (9)
Arizona
- Abrazo Arizona Heart Hospital - Phoenix
California
- Kaiser Permanente - San Diego
Louisiana
- CIS Grey ASC - Gray
Maryland
- MedStar Health Research Institute - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Missouri
- The Washington University - St Louis
North Carolina
- University of North Carolina Chapel Hill - Chapel Hill
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2029-04 |
| Phase | Phase 4 |
What NCT06777901 shows while recruiting
NCT06777901 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Peripheral Arterial Diseases appearing as the primary indexed condition, and to 2 interventions - of which Auryon Atherectomy System is the first listed.
NCT06777901 lists 9 locations in 9 states (Arizona, California, Louisiana).
Frequently Asked Questions
What is clinical trial NCT06777901 about?
NCT06777901 is a clinical study titled "Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone". The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, am...
What is the current status of trial NCT06777901?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 224 participants. The study started on 2025-04-21. Estimated completion is 2029-04.
What conditions does trial NCT06777901 study?
This clinical trial studies the following conditions: Peripheral Arterial Diseases.
What interventions are being tested in trial NCT06777901?
The interventions under investigation include: Auryon Atherectomy System (DEVICE), Balloon Angioplasty (DEVICE).
Who is sponsoring clinical trial NCT06777901?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06777901 being conducted?
This trial has 9 study locations across Arizona, California, Louisiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06777901's enrollment target sits among peer trials
224 379th of 2000 higher than 1,619 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI